IP Library Granted Patent US 9,861,580
Granted Patent B2
US 9,861,580 · App. 13/001,630 · Granted Jan 9, 2018

Method of making a dry powder pharmaceutical composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,580
App. No.
13/001,630
Granted
Jan 9, 2018
Kind
B2
Abstract

A method of making active pharmaceutical ingredient particles with surface-modified nanoparticles deposited on the particles' surfaces, the method comprising: providing a plurality of media particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; mixing the plurality of media particles with the active ingredient particles, both of which are in dry form, to provide active ingredient particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and separating the plurality of media particles from the active ingredient particles having surfaces with the surface-modified nanoparticles deposited on the surfaces is disclosed.

Claims (24)

1. A method of making active pharmaceutical ingredient particles having surfaces with surface-modified nanoparticles deposited thereon, the method comprising:

providing a plurality of media particles having surfaces with surface-modified nanoparticles deposited on the surfaces of the media particles;

mixing the plurality of media particles with active ingredient particles to transfer surface-modified nanoparticles from the media particles to the active ingredient particles and provide active ingredient particles having surfaces with a portion of the surface-modified nanoparticles deposited thereon; and

subsequently, separating the plurality of media particles from the active ingredient particles having surfaces with the portion of the surface-modified nanoparticles deposited thereon;

wherein the media particles have at least one feature which is different from at least one feature of the active ingredient such that the media particles can be separated from the active ingredient particles.

2. The method of claim 1 , further comprising treating a plurality of media particles with surface-modified nanoparticles to provide the media particles having surfaces with the surface-modified nanoparticles deposited on the surfaces.

3. The method of claim 2 , wherein treating the plurality of media particles with the surface-modified nanoparticles is carried out by mixing the media particles with the surface-modified nanoparticles in a liquid, and then removing the liquid; and wherein the media particles are substantially insoluble in the liquid, and the surface-modified nanoparticles are dispersible in the liquid.

4. The method of claim 3 , wherein the liquid is selected from the group consisting of water, an alcohol, a hydrocarbon, a fluorocarbon, a supercritical fluid, and a combination thereof.

5. The method of claim 3 , wherein the liquid is removed by rotary evaporation, bulk evaporation, spray drying, or freeze drying.

6. The method of claim 2 , wherein treating the plurality of media particles with the surface-modified nanoparticles is carried out by dry blending the media particles with the surface-modified nanoparticles.

7. The method of claim 2 , wherein treating the plurality of media particles with surface-modified nanoparticles comprises the step of spraying a liquid dispersion of surface-modified nanoparticles onto the media particles.

8. The method of claim 1 , wherein mixing the plurality of media particles with the active ingredient particles to provide active ingredient particles having surfaces with the portion of the surface-modified nanoparticles deposited on the surfaces of the active pharmaceutical ingredient particles is carried out by dry blending the plurality of media particles with the active ingredient particles, which are both in dry form.

9. The method of claim 1 , wherein the at least one feature is selected from the group consisting of particle diameter, particle aspect ratio, particle density, particle solubility, particle attraction to a magnetic field, particle repulsion from a magnetic field, and a combination thereof.

10. The method of claim 9 , wherein the at least one feature includes particle diameter, and wherein at least 99 percent by weight of the media particles have a particle diameter at least 10 fold greater than the particle diameter of at least 99 percent by weight of the active ingredient particles.

11. The method of claim 9 , wherein the at least one feature includes particle density, wherein at least 99 percent by weight of the media particles have a particle density at least 2 fold greater than the particle density of at least 99 percent by weight of the active ingredient particles.

12. The method of claim 1 , wherein the media particles have a mean physical diameter of 200 micrometers to 5000 micrometers.

13. The method of claim 1 , wherein the active ingredient particles are micronized.

14. The method of claim 1 , wherein the active ingredient particles have a mass median aerodynamic diameter of at least 1 micrometer and less than 5 micrometers.

15. The method of claim 1 , wherein when mixing the plurality of media particles with the active ingredient particles, the active ingredient particles and the media particles are each present in an amount such that the weight ratio of the amount of active ingredient particles to the amount of the media particles is not more than 1:10.

16. The method of claim 1 , wherein the media particles are non-friable.

17. The method of claim 1 , wherein the surface-modified nanoparticles comprise a core, the core comprising an organic core or an inorganic material selected from the group consisting of silica, titania, alumina, an oxide of zinc, an oxide of iron, metal phosphates, metal sulfates, metal chlorides, or a combination thereof.

18. The method of claim 17 , wherein a surface of the core is modified with a compound selected from the group consisting of alkylsilanes, carboxylic acids, phosphonic acids, sulfonates, polyethylene glycols, sugars, and a combination thereof.

19. The method of claim 1 , wherein the surface-modified nanoparticles have a mean diameter of not more than 20 nanometers.

20. The method of claim 1 , wherein the surface-modified nanoparticles deposited on the surfaces of the media particles are present in an amount of at least 0.1 percent and not more than 10 percent by weight of the media particles.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2010
From: MUETING, MICHAEL W.; DUAN, DANIEL C.; STEIN, STEPHEN W.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 025540/0879 →